Capillary Technologies IPO Subscribed 0.28x on Day 1

Capillary Technologies IPO subscription started on Friday, November 14, 2025, and will close on November 18, 2025, as per the schedule. The price band is set at ₹549 to ₹577 per share with a face value of ₹2.

Table of Contents

Capillary Technologies IPO Subscription Status

Capillary Technologies IPO subscribed over 0.28x on its First day till 05.00 PM on 14th November 2025.

  • Capillary Technologies IPO subscription QIB investor portion is 0.29x times, while NII subscribed 0.28x times, and RII investors subscribed 0.27x times.
  • The company has received bids for 23,88,150 shares against 83,79,998 shares on offer on the First day. 
  • Capillary Technologies IPO subscribed over 0.28x times on day 1. 

About the Capillary Technologies IPO

Capillary Technologies is a software product company offering artificial intelligence (“AI”)-based cloud-native Software-as-aService (“SaaS”) products and solutions primarily to Enterprise Customers (defined as customers contributing more than ₹ 8.00 million in revenue from operations in a Fiscal year) globally to develop loyalty of their consumers and channel partners.

The firm’s growth reason is its skilled and experienced team members. Moreover, also, the company has great and unique strengths, such as the company is considered one of the greatest firms in terms of loyalty solutions. 

Moreover, Capillary Technologies India Ltd has a 14% increment in revenue and a 122% increase in profit after tax (PAT) from FY 2024 to FY 2025.

Capillary Technologies IPO Company Financial Report

The company reported revenue of ₹611.87 crores in 2025 against ₹535.44 crores in 2024. The company reported a profit of ₹13.28 crores in 2025 against a loss of ₹59.38 crores in 2024. 

Capillary Technologies IPO GMP

Capillary Technologies IPO GMP was ₹0 as of Friday, 14th November. That indicates the IPO is trading at ₹577 with a ₹0 premium in the grey market against the issue price of ₹577.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *